[
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals: Buying The CF Fortress For The Journavx Optionality",
    "summary": "Vertex Pharmaceuticals is backed by CF dominance and JOURNAVX optionality, with key catalysts ahead for growth and upside. See why VRTX stock is a buy.",
    "url": "https://finnhub.io/api/news?id=8e385852a6bc51ffe564d6f18c3daef8593a1587547b1b5211e3c9740bf18d20",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757751580,
      "headline": "Vertex Pharmaceuticals: Buying The CF Fortress For The Journavx Optionality",
      "id": 136733501,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1832921718/image_1832921718.jpg?io=getty-c-w1536",
      "related": "VRTX",
      "source": "SeekingAlpha",
      "summary": "Vertex Pharmaceuticals is backed by CF dominance and JOURNAVX optionality, with key catalysts ahead for growth and upside. See why VRTX stock is a buy.",
      "url": "https://finnhub.io/api/news?id=8e385852a6bc51ffe564d6f18c3daef8593a1587547b1b5211e3c9740bf18d20"
    }
  }
]